Rh factor is a protein found on the surface of red blood cells. If your red blood cells carry this protein, your blood type is Rh positive. If they don’t, you’re Rh negative. It’s the “positive” or “negative” label attached to your blood type, so someone who is A+ has type A blood with the Rh protein, while someone who is O- has type O blood without it. Roughly 85% of people are Rh positive, though the exact number varies by ethnic background and geography.
What the Rh Protein Actually Does
The Rh protein (formally called RhD) sits embedded in the membrane of each red blood cell, anchored by twelve segments that pass back and forth through the cell wall. It’s part of a larger cluster of proteins that help maintain the structural integrity of the red blood cell membrane. Without this complex, red blood cells become fragile and misshapen. The protein may also play a role in transporting ammonia, a waste product, out of the blood.
Being Rh negative doesn’t mean your red blood cells are defective. People who are Rh negative simply lack the RhD protein entirely, and their red blood cells function normally. The distinction only becomes medically important in two situations: blood transfusions and pregnancy.
How Rh Factor Is Inherited
Your Rh status is determined by genetics. The RhD gene, which codes for the protein, sits on chromosome 1. If you inherit at least one working copy of this gene from either parent, your blood cells will produce the protein and you’ll be Rh positive. The gene is dominant, meaning one copy is enough.
People who are Rh negative don’t just have a switched-off version of the gene. In most cases, the entire RhD gene is physically missing from both copies of chromosome 1. This deletion happened during human evolution through a shuffling error when DNA was copied, and it became common enough that a significant portion of the population now carries it. About 17% of people in Britain are Rh negative, while in Northern India the rate is closer to 4.3%. Populations of African and East Asian descent tend to fall somewhere in between, with some African populations carrying altered versions of the gene rather than a complete deletion.
Because the gene is dominant, two Rh-positive parents can still have an Rh-negative child if both carry one deleted copy. Each parent passes on one copy, and if the child happens to inherit the deleted version from both, they’ll be Rh negative.
How Rh Factor Is Tested
Rh typing is done alongside ABO blood typing and takes only minutes. A technician mixes a drop of your blood with a reagent containing anti-D antibodies. If your red blood cells carry the Rh protein, they’ll clump together visibly. No clumping means you’re Rh negative.
In emergencies, a rapid slide method can deliver results in five to ten minutes. For routine testing in hospitals and blood banks, an automated gel-based method is more common because it’s standardized and easier to quality-control. Pregnant women and anyone awaiting a blood transfusion are routinely tested for both ABO type and Rh status. In some cases, particularly with newborns, the protein can be present in such small amounts that the initial test comes back falsely negative, requiring a more sensitive follow-up test.
Why Rh Factor Matters for Transfusions
If you’re Rh negative and you receive Rh-positive blood, your immune system may recognize the Rh protein as foreign and produce antibodies against it. This doesn’t usually cause a dramatic reaction the first time, but once those antibodies exist, any future exposure to Rh-positive blood can trigger your immune system to destroy the transfused red blood cells. This is called a delayed hemolytic transfusion reaction, and it can cause fever, anemia, and organ stress.
The compatibility rule is straightforward: Rh-negative patients should receive Rh-negative blood. Rh-positive patients can safely receive either Rh-positive or Rh-negative blood, since their immune system already recognizes the protein as normal. Donated red blood cells must lack any major antigens that the recipient’s own cells lack.
Rh Incompatibility During Pregnancy
The most well-known consequence of Rh factor involves pregnancy. If an Rh-negative mother carries an Rh-positive baby, small amounts of the baby’s blood can cross into her bloodstream during delivery, a miscarriage, abdominal trauma, or certain obstetric procedures. Her immune system detects the unfamiliar Rh protein and begins producing antibodies against it. This process is called Rh sensitization.
The first pregnancy is usually unaffected because the antibody response takes time to build. The danger comes with subsequent pregnancies. If the next baby is also Rh positive, the mother’s pre-existing antibodies can cross the placenta and attack the baby’s red blood cells. This destroys red blood cells faster than the baby can replace them, leading to a condition called hemolytic disease of the fetus and newborn.
The severity ranges widely. In mild cases, the baby is born with elevated bilirubin (a breakdown product of destroyed red blood cells) and mild jaundice, which is treated with phototherapy, a special light that helps the baby’s body process bilirubin through the skin. In severe cases, the baby can develop dangerous anemia while still in the womb. Doctors monitor for this using ultrasound to measure blood flow speed in the baby’s brain arteries. When blood becomes thinner from anemia, it flows faster, so an abnormally high flow rate signals that the baby needs intervention, sometimes including a blood transfusion delivered through the umbilical cord before birth.
How Rh Sensitization Is Prevented
Rh sensitization is almost entirely preventable. Rh-negative mothers who are carrying an Rh-positive baby (or whose baby’s Rh status is unknown) receive an injection of Rh immunoglobulin, commonly known by the brand name RhoGAM. This is a concentrated dose of anti-Rh antibodies that finds and destroys any of the baby’s red blood cells that have entered the mother’s bloodstream before her own immune system can react and form a lasting antibody response.
The standard timing is an injection at 28 to 30 weeks of pregnancy, with a second dose given within 72 hours after delivery if the baby is confirmed Rh positive. Additional doses may be given after any event that could cause the baby’s blood to mix with the mother’s, such as an amniocentesis, a fall, or bleeding during pregnancy. Since this preventive treatment became routine in the late 1960s, hemolytic disease of the newborn from Rh incompatibility has dropped dramatically in countries where it’s widely available.
Rh-Negative Blood and Supply Concerns
Because Rh-negative blood can be given to both Rh-positive and Rh-negative patients in emergencies, it’s in constant demand at blood banks. O-negative blood in particular is considered the universal red cell donor type and is the go-to choice when there’s no time to test a patient’s blood type. But Rh-negative donors make up a relatively small fraction of the population, so shortages are common. The frequency varies significantly: about 17% of the population in Britain is Rh negative, compared to just 4.3% in parts of Northern India. If you’re Rh negative, your donations are especially valuable to the blood supply.